SCHEMBL14381277

SCHEMBL14381277

O=C1NC(=O)[C@H]2C3CCC(O3)[C@@H]12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.56
PPM1B O75688 5/20 0.56
LMNA P02545 4/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
KDM4E B2RXH2 3/20 0.56
GMNN O75496 3/20 0.56
TFPI2 P48307 3/20 0.56
PMP22 Q01453 3/20 0.56
NFKB1 P19838 3/20 0.56
THPO P40225 3/20 0.56
RAB9A P51151 3/20 0.56
PPP1CC P36873 2/20 0.56
PPP5C P53041 2/20 0.56
PPP1CA P62136 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
CYP2D6 P10635 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.36
TSHR P16473 2/20 0.35
CYP3A4 P08684 3/20 0.30
MAPK1 P28482 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17773447 1.00 TP53 (0.56) TP53PPM1BLMNASMN1; SMN2KDM4E
SCHEMBL13311452 1.00 TP53 (0.56) TP53PPM1BLMNASMN1; SMN2KDM4E
SCHEMBL2548229 1.00 TP53 (0.56) TP53PPM1BLMNASMN1; SMN2KDM4E
Demethyl-Cantharidin SCHEMBL19318920 0.72 TP53 (1.00) TP53PPM1BLMNASMN1; SMN2KDM4E
Demethyl-Cantharidin SCHEMBL9675442 0.72 TP53 (1.00) TP53PPM1BLMNASMN1; SMN2KDM4E
Demethyl-Cantharidin SCHEMBL3195020 0.72 TP53 (1.00) TP53PPM1BLMNASMN1; SMN2KDM4E
SCHEMBL2120400 0.72 PPM1B (0.56) TP53PPM1BLMNASMN1; SMN2KDM4E
Demethyl-Cantharidin SCHEMBL177729 0.72 TP53 (1.00) TP53PPM1BLMNASMN1; SMN2KDM4E
SCHEMBL13556829 0.72 PPM1B (0.56) TP53PPM1BLMNASMN1; SMN2KDM4E
SCHEMBL407914 0.72 PPM1B (0.56) TP53PPM1BLMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1854798-A2 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Bristol-Myers Squibb Company (US) 2007-11-14 EP disclosed